Comparison of Two Different Doses of Vitamin D in Preterm Infants
A Randomized Controlled Trial Comparing Two Regimens of Vitamin D Supplementation in Preterm Neonates
1 other identifier
interventional
80
1 country
1
Brief Summary
randomized clinical trial comparing two different doses of vitamin d supplementation in preterm infants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2019
CompletedFirst Posted
Study publicly available on registry
March 26, 2019
CompletedStudy Start
First participant enrolled
April 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedApril 26, 2019
April 1, 2019
2 months
March 22, 2019
April 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Compare the level of serum 25 hydroxy vitamin D between the two groups of newborns. 2- Detect vitamin D deficiency among both groups.
measurement of the level after supplementation
1 month
Study Arms (2)
400 iu
EXPERIMENTALneonates who will receive vitamin d dose at 400 iu per day
1000 iu
ACTIVE COMPARATORneonates who will receive vitamin d dose 1000 iu per day
Interventions
vitamin d drops will be given daily to the 2 groups of neonates ( 1st group will be given 400 iu /day and 2nd group will be given 1000 iu per day ) when they reach 100 cc per kg enteral feeding .. until they reach 40 weeks gestational age
Eligibility Criteria
You may qualify if:
- Preterm infants delivered at a gestational age ≤ 32 weeks
- Birth weight ≤1500 kg
You may not qualify if:
- Neonates with major congenital anomalies,
- maternal condition or medications likely to influence vitamin D or calcium metabolism
- neonates not receiving 100 ml/ kg / day of enteral feeds by 14 days of life
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Kasr alainy
Cairo, 002, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 22, 2019
First Posted
March 26, 2019
Study Start
April 16, 2019
Primary Completion
June 15, 2019
Study Completion
June 30, 2019
Last Updated
April 26, 2019
Record last verified: 2019-04